Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host-Microbiome Interaction in Lung Cancer
Qiang Dong, Eric S. Chen, Chen Zhao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The dynamic lung microbiome in health and disease
Jake G. Natalini, Shivani Singh, Leopoldo N. Segal
Nature Reviews Microbiology (2022) Vol. 21, Iss. 4, pp. 222-235
Open Access | Times Cited: 270
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Yan Chen, Fahong Wu, Pengqiang Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature
Abigail Wong-Rolle, Qiang Dong, Yunhua Zhu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004698-e004698
Open Access | Times Cited: 47
Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing
Yi‐Fan Sun, Yuejiao Liu, Jianjie Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 28
Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer
Haiming Chen, Yi Ma, Juqing Xu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101499-101499
Open Access | Times Cited: 12
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 8
A snapshot of lung cancer: where are we now?—a narrative review
GOGO-OGUTE E IBODENG, Ifeanyi Nnamdi Uche, Ruth Mokua, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 6, pp. 261-261
Open Access | Times Cited: 18
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer
Maximilian Boesch, Florent Baty, Werner C. Albrich, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 40
The Lung Microbiota and Lung Cancer: A Growing Relationship
Maroun Bou Zerdan, Joseph Kassab, Paul Meouchy, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4813-4813
Open Access | Times Cited: 24
Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
Paraskevi Vryza, Timo Fischer, Elena Mistakidi, et al.
Translational Oncology (2023) Vol. 38, pp. 101788-101788
Open Access | Times Cited: 15
Oxidative stress induced by Etoposide anti-cancer chemotherapy drives the emergence of tumor-associated bacteria resistance to fluoroquinolones
Shan Wang, Shepherd Yuen Chan, Yanlin Deng, et al.
Journal of Advanced Research (2023) Vol. 55, pp. 33-44
Open Access | Times Cited: 14
Metagenomic next-generation sequencing for lung cancer low respiratory tract infections diagnosis and characterizing microbiome features
Yao Liu, Bohan Yang, Qi Qi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Role of microbiome in cancer progression
Rinki Basoya, Baldeep Singh, Akshay Basi, et al.
International review of cell and molecular biology (2025)
Closed Access
Study on the application value of “micro-aspiration” in prevention and control of ventilator-related pneumonia in severely ill patients: A randomized controlled trial
Rong Zhang, Jing Liu, Wei Jin, et al.
AIP Advances (2025) Vol. 15, Iss. 2
Open Access
Polyacetylenes from Codonopsis lanceolata Root Induced Apoptosis of Human Lung Adenocarcinoma Cells and Improved Lung Dysbiosis
Meng-chuan Wang, Yufang Wu, Wen-Ying Yu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 20
Bacterial infection and microbiota in carcinogenesis and tumor development
Qiao Li
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Crosstalk between the lung microbiome and lung cancer
Yuting Meng, Yu Mao, Zhongxiang Tang, et al.
Microbial Pathogenesis (2023) Vol. 178, pp. 106062-106062
Closed Access | Times Cited: 11
Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets
Hao‐Shuai Yang, Jin Zhang, Hongxiang Feng, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Research status of the relationship between microecological imbalance and lung cancer
Xin Jin, Yunna Gu, Xiaojie Song
Frontiers in Microbiology (2025) Vol. 16
Open Access
Clinical characteristics and risk factors of late-stage lung adenocarcinoma patients with bacterial pulmonary infection and its relationship with cellular immune function
Kangli Yang, Haiting Wei, Weiwei Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lung microbiome: an emerging player in lung cancer pathogenesis and progression
Alexandra Karvela, Orsalia-Zoi Veloudiou, Anastasia Karachaliou, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 8, pp. 2365-2372
Closed Access | Times Cited: 10
The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
Yurong Du, Lei Liu, Wang Ma, et al.
The Innovation Life (2023) Vol. 1, Iss. 2, pp. 100016-100016
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top